Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04237168
What this trial is testing

Non-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Testing effectiveness (Phase 2)UnknownNCT02878278
What this trial is testing

Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation

Who this might be right for
Lymphoma, Extranodal NK-T-CellEBV
Huiqiang Huang 24
Not applicableEnded earlyNCT00594308
What this trial is testing

In-Vivo Activated T-Cell Depletion to Prevent GVHD

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Indiana University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03179917
What this trial is testing

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 22
Not applicableApproved For MarketingNCT05733650
What this trial is testing

Expanded Access Program for Epcoritamab

Who this might be right for
Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+2 more
Genmab
Testing effectiveness (Phase 2)UnknownNCT02267915
What this trial is testing

Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT

Who this might be right for
Mantle-cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 36
Testing effectiveness (Phase 2)Study completedNCT00002635
What this trial is testing

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Who this might be right for
Lymphoma
Yale University 12
Testing effectiveness (Phase 2)Study completedNCT01779791
What this trial is testing

PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma

Who this might be right for
Lymphoma
Janssen Research & Development, LLC 110
Early research (Phase 1)Study completedNCT00256191
What this trial is testing

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Who this might be right for
NeoplasmsHodgkin's DiseaseNon-Hodgkin's Lymphoma
Cortice Biosciences, Inc. 45
Testing effectiveness (Phase 2)UnknownNCT02846584
What this trial is testing

A Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLeukemia, Lymphocytic, Chronic, B-CellLymphoma，Malignant
Southwest Hospital, China 100
Early research (Phase 1)UnknownNCT02842138
What this trial is testing

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Peking University 25
Early research (Phase 1)Looking for participantsNCT07478848
What this trial is testing

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Who this might be right for
Large B Cell LymphomaNon Hodgkin Lymphoma (NHL)Diffuse Large B Cell Lymphoma (DLBCL)+2 more
Abramson Cancer Center at Penn Medicine 14
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Large-scale testing (Phase 3)Active Not RecruitingNCT00005584
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,649
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Looking for participantsNCT03418038
What this trial is testing

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more
Mayo Clinic 80
Testing effectiveness (Phase 2)UnknownNCT00333008
What this trial is testing

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Who this might be right for
Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin
The Alvin and Lois Lapidus Cancer Institute 27
Not applicableUnknownNCT05840289
What this trial is testing

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma

Who this might be right for
Aggressive B-Cell Non-Hodgkin Lymphoma
University Hospital, Geneva 94
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Not applicableLooking for participantsNCT05326308
What this trial is testing

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

Who this might be right for
Waldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone Lymphoma+1 more
iOMEDICO AG 845
Next Page